Barclays’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.16M | Sell |
32,730
-87,475
| -73% | -$3.56M | ﹤0.01% | 2671 |
|
|
2025
Q4 | $4.88M | Sell |
120,205
-6,530
| -5% | -$284K | ﹤0.01% | 2239 |
|
|
2025
Q3 | $5.96M | Sell |
126,735
-27,783
| -18% | -$1.44M | ﹤0.01% | 2056 |
|
|
2025
Q2 | $8.05M | Sell |
154,518
-29,455
| -16% | -$1.62M | ﹤0.01% | 1724 |
|
|
2025
Q1 | $11.1M | Sell |
183,973
-78,339
| -30% | -$5.05M | ﹤0.01% | 1333 |
|
|
2024
Q4 | $18M | Sell |
262,312
-27,475
| -9% | -$1.91M | 0.01% | 1192 |
|
|
2024
Q3 | $20.8M | Buy |
289,787
+32,467
| +13% | +$2.29M | 0.01% | 1049 |
|
|
2024
Q2 | $17.8M | Sell |
257,320
-77,160
| -23% | -$5.63M | 0.01% | 976 |
|
|
2024
Q1 | $26.8M | Sell |
334,480
-113,455
| -25% | -$10.1M | 0.01% | 869 |
|
|
2023
Q4 | $49.1M | Buy |
447,935
+60,340
| +16% | +$6.24M | 0.02% | 680 |
|
|
2023
Q3 | $39.1M | Buy |
387,595
+22,410
| +6% | +$2.57M | 0.02% | 563 |
|
|
2023
Q2 | $49.6M | Sell |
365,185
-10,191
| -3% | -$1.24M | 0.03% | 452 |
|
|
2023
Q1 | $39M | Buy |
375,376
+158,759
| +73% | +$15.4M | 0.02% | 578 |
|
|
2022
Q4 | $19.2M | Buy |
216,617
+54,719
| +34% | +$4.54M | 0.01% | 913 |
|
|
2022
Q3 | $13M | Sell |
161,898
-985
| -0.6% | -$92.9K | 0.01% | 763 |
|
|
2022
Q2 | $15.6M | Sell |
162,883
-39,488
| -20% | -$4.74M | 0.01% | 824 |
|
|
2022
Q1 | $30.1M | Sell |
202,371
-23,770
| -11% | -$3.32M | 0.02% | 565 |
|
|
2021
Q4 | $32.1M | Buy |
226,141
+13,230
| +6% | +$1.87M | 0.01% | 745 |
|
|
2021
Q3 | $27.9M | Buy |
212,911
+21,591
| +11% | +$2.82M | 0.01% | 759 |
|
|
2021
Q2 | $26.3M | Sell |
191,320
-23,556
| -11% | -$3.23M | 0.01% | 764 |
|
|
2021
Q1 | $28.1M | Sell |
214,876
-5,410
| -2% | -$651K | 0.02% | 664 |
|
|
2020
Q4 | $24.7M | Buy |
220,286
+6,186
| +3% | +$586K | 0.01% | 748 |
|
|
2020
Q3 | $16.8M | Buy |
214,100
+24,210
| +13% | +$1.97M | 0.01% | 818 |
|
|
2020
Q2 | $13.7M | Sell |
189,890
-23,525
| -11% | -$1.64M | 0.01% | 816 |
|
|
2020
Q1 | $12.2M | Sell |
213,415
-46,023
| -18% | -$4.24M | 0.01% | 882 |
|
|
2019
Q4 | $29M | Sell |
259,438
-17,938
| -6% | -$1.91M | 0.02% | 750 |
|
|
2019
Q3 | $26.7M | Buy |
277,376
+5,984
| +2% | +$562K | 0.02% | 724 |
|
|
2019
Q2 | $23.2M | Buy |
271,392
+18,353
| +7% | +$1.51M | 0.01% | 836 |
|
|
2019
Q1 | $21M | Buy |
253,039
+234,417
| +1,259% | +$17M | 0.01% | 828 |
|
|
2018
Q4 | $1.2M | Sell |
18,622
-18,546
| -50% | -$1.27M | ﹤0.01% | 2936 |
|
|
2018
Q3 | $2.94M | Buy |
37,168
+16,425
| +79% | +$1.27M | ﹤0.01% | 2434 |
|
|
2018
Q2 | $1.52M | Buy |
20,743
+7,668
| +59% | +$521K | ﹤0.01% | 2831 |
|
|
2018
Q1 | $827K | Buy |
13,075
+4,782
| +58% | +$285K | ﹤0.01% | 3438 |
|
|
2017
Q4 | $423K | Buy |
8,293
+4,250
| +105% | +$221K | ﹤0.01% | 4024 |
|
|
2017
Q3 | $212K | Sell |
4,043
-106
| -3% | -$5.32K | ﹤0.01% | 4376 |
|
|
2017
Q2 | $211K | Sell |
4,149
-14
| -0.3% | -$693 | ﹤0.01% | 4310 |
|
|
2017
Q1 | $185K | Buy |
4,163
+1,895
| +84% | +$81.5K | ﹤0.01% | 4401 |
|
|
2016
Q4 | $101K | Buy |
2,268
+1,704
| +302% | +$72.4K | ﹤0.01% | 4732 |
|
|
2016
Q3 | $23K | Sell |
564
-9,317
| -94% | -$396K | ﹤0.01% | 5393 |
|
|
2016
Q2 | $472K | Buy |
+9,881
| New | +$418K | ﹤0.01% | 3268 |
|
|
2015
Q4 | – | Sell |
-144
| Closed | -$7K | – | 6046 |
|
|
2015
Q3 | $7K | Sell |
144
-385
| -73% | -$21.1K | ﹤0.01% | 5912 |
|
|
2015
Q2 | $31K | Sell |
529
-289
| -35% | -$15.6K | ﹤0.01% | 5427 |
|
|
2015
Q1 | $41K | Sell |
818
-3,488
| -81% | -$171K | ﹤0.01% | 5410 |
|
|
2014
Q4 | $189K | Sell |
4,306
-2,453
| -36% | -$103K | ﹤0.01% | 4688 |
|
|
2014
Q3 | $243K | Sell |
6,759
-4,863
| -42% | -$193K | ﹤0.01% | 4560 |
|
|
2014
Q2 | $511K | Sell |
11,622
-4,117
| -26% | -$187K | ﹤0.01% | 3949 |
|
|
2014
Q1 | $677K | Buy |
15,739
+2,070
| +15% | +$92.2K | ﹤0.01% | 3653 |
|
|
2013
Q4 | $574K | Sell |
13,669
-8,244
| -38% | -$313K | ﹤0.01% | 3960 |
|
|
2013
Q3 | $723K | Sell |
21,913
-1,965
| -8% | -$64.1K | ﹤0.01% | 3700 |
|
|
2013
Q2 | $746K | Buy |
+23,878
| New | +$775K | ﹤0.01% | 3740 |
|
Other funds holding CNMD
VPM
VCM
CB
Barclays's CNMD Position: Q1 2026 in Review
Barclays reduced its CONMED (CNMD) stake by 73% in Q1 2026, selling an estimated $3.56M and leaving 32,730 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2671.
Barclays first reported a position in CNMD in Q2 2013 and has held it in 50 quarters since. The position peaked at $49.6M in Q2 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Barclays held 32,730 shares of CONMED worth $1.16M as of Q1 2026.
- Barclays sold 87,475 CONMED shares in Q1 2026, an estimated $3.56M.
- CONMED made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2671 holding.
- Barclays first reported a position in CONMED in Q2 2013 and has held it in 50 quarters since.
- Barclays's CONMED position peaked at $49.6M in Q2 2023.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.